Cambrex Corp. (CBM) Tops Q4 EPS by 14c

Go back to Cambrex Corp. (CBM) Tops Q4 EPS by 14c

Cambrex Corp. (CBM) Plans Significant Expansion to Charles City Facility

February 6, 2015 7:11 AM EST

Cambrex Corp. (NYSE: CBM) has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continued growth in demand for the Company's active pharmaceutical ingredient (API) contract manufacturing capabilities is driving the need for more capacity. The Company expects to invest between $45 and $50 million during 2015, including a state of the art cGMP production facility and related supporting infrastructure. This project is expected to be completed in early 2016 and is designed to allow... More